Develops enzymes for RNA interference therapeutics manufacturing.
Jun 2026Revenue $77.7M/yrExpenses $105M/yr
No trendCash runway ≈ 4.5 years from Jun 2026
Figures by year
When will Codexis be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $77.7M and expenses $105M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $70.4M | $112M | −$41.7M |
| Dec 2024 | $59.3M | $118M | −$58.5M |
| Dec 2023 | $70.1M | $138M | −$68.1M |
| Dec 2022 | $139M | $173M | −$34.9M |
| Dec 2021 | $105M | $127M | −$22.7M |
| Dec 2020 | $69.1M | $93.0M | −$23.9M |
| Dec 2019 | $68.5M | $81.0M | −$12.5M |
| Dec 2018 | $60.6M | $71.9M | −$11.3M |
| Dec 2017 | $50.0M | $73.0M | −$23.0M |
| Dec 2016 | $48.8M | $57.4M | −$8.56M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.